View Single Post
Old Thu Dec 12, 2013, 07:20 AM
Mseth Mseth is offline
Join Date: Sep 2013
Location: New Delhi, India
Posts: 186

Hi all,

In the ASCO update on MDS Beacon, there is some positive news on Estybon, for low risk transfusion dependent showing 50% success rate. Is this something to look forward to in the near future?
Mother age 79, dx MDS RCMD low risk del 20q April 2013, no response to EPO, Danazol. pRBC tx dependent - 2 units every 3-4 weeks, exjade Dec 2013 - Mar2014, restarted Dec 2014
Reply With Quote